title: The emerging role of pharmacogenetics: implications for clinical psychiatry.
abstract: OBJECTIVE
  This article aims to review the implications of pharmacogenetics for clinical psychiatry; these are discussed in the context of environmental and sociocultural factors.
  
  
  METHODS
  A selective literature review was conducted using Medline search and other relevant references available to the authors.
  
  
  RESULTS
  The individual differences in therapeutic and adverse effects of psychotropic drugs are largely determined by genetic factors. Recent advances in pharmacogenetics have highlighted the potential utility in predicting metabolic phenotypes, risks for side-effects and likelihood of drug response for the individual patient.
  
  
  CONCLUSIONS
  Genotyping, especially for drug metabolizing enzymes, could enable more rational, cost-effective and optimal prescribing in future psychopharmacotherapy. Although the advances of pharmacogenetics may have many benefits in clinical practice, the importance of non-genetic factors must also be considered as cultural and environmental factors significantly impinge on response to medications. To clarify the extent pharmacogenetics can be adopted in clinical practice to predict drug response in patients from diverse backgrounds, further studies in different ethnic groups and clinical settings are required.
authors.affiliation: The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Victoria, Australia. cng@unimelb.edu.au
authors.forename: Chee Hong
authors.initials: CH
authors.lastname: Ng
authors.forename: Isaac
authors.initials: I
authors.lastname: Schweitzer
authors.forename: Trevor
authors.initials: T
authors.lastname: Norman
authors.forename: Simon
authors.initials: S
authors.lastname: Easteal
mesh_terms: D003362:Cost-Benefit Analysis; D003469:Culture; D004351:Drug Resistance; D004777:Environment; D005544:Forecasting; D005838:Genotype; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000235:genetics*; D010597:Pharmacogenetics / Q000191:economics* / Q000639:trends*; D011570:Psychiatry / Q000379:methods*; D011584:Psychology; D011600:Psychopharmacology / Q000191:economics* / Q000639:trends*; D011619:Psychotropic Drugs / Q000145:classification / Q000191:economics / Q000378:metabolism
chemical_list: D011619:Psychotropic Drugs